These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37335135)

  • 1. Prevalence and Burden of Illness of Rome IV Chronic Idiopathic Constipation, Opioid-Induced Constipation, and Opioid-Exacerbated Constipation in the United States.
    Liang J; Almario CV; Chey WD; Higgins CS; Spiegel BMR
    Am J Gastroenterol; 2023 Nov; 118(11):2033-2040. PubMed ID: 37335135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid-induced constipation in patients with cancer: a "real-world," multicentre, observational study of diagnostic criteria and clinical features.
    Davies A; Leach C; Butler C; Gregory A; Henshaw S; Minton O; Shorthose K; Batsari KM
    Pain; 2021 Jan; 162(1):309-318. PubMed ID: 32701649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.
    Palsson OS; Whitehead W; Törnblom H; Sperber AD; Simren M
    Gastroenterology; 2020 Apr; 158(5):1262-1273.e3. PubMed ID: 31917991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of constipation on opioid therapy management among long-term opioid users, based on a patient survey.
    Gupta S; Patel H; Scopel J; Mody RR
    J Opioid Manag; 2015; 11(4):325-38. PubMed ID: 26312960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports.
    LoCasale RJ; Datto C; Wilson H; Yeomans K; Coyne KS
    J Manag Care Spec Pharm; 2016 Mar; 22(3):236-45. PubMed ID: 27003553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' Self-Assessment of the Symptoms and Impact of Opioid-Induced Constipation: Results From a Prospective Observational Cohort Study of Japanese Patients With Cancer.
    Fumita S; Imai H; Harada T; Noriyuki T; Gamoh M; Akashi Y; Sato H; Kizawa Y; Tokoro A
    J Pain Symptom Manage; 2020 May; 59(5):1043-1051.e2. PubMed ID: 31805362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inadequate management of opioid-induced constipation in European cancer pain patients: results of a real-world, multicentre, observational study ("E-StOIC").
    Davies A; Fagan N; Gonzalez-Barboteo J; Chelazzi C; Economos G; Elsner F; Leach C; Monsen RE; Oldenmenger WH; Remi C; van den Beuken-van Everdingen M; Wüstefeld M
    Support Care Cancer; 2024 Oct; 32(10):701. PubMed ID: 39367106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer.
    Harada T; Imai H; Fumita S; Noriyuki T; Gamoh M; Okamoto M; Akashi Y; Kizawa Y; Tokoro A
    Int J Clin Oncol; 2021 Jan; 26(1):104-110. PubMed ID: 33068220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-Related Constipation.
    Liu JJ; Brenner DM
    Gastroenterol Clin North Am; 2022 Mar; 51(1):107-121. PubMed ID: 35135657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Functional Characteristics of Nursing Facility Residents with Opioid-Induced Constipation.
    Allen C; Zarowitz BJ; O'Shea T; Datto C; Olufade T
    Consult Pharm; 2017 May; 32(5):285-298. PubMed ID: 28483009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium hydroxide versus macrogol/electrolytes in the prevention of opioid-induced constipation in incurable cancer patients: study protocol for an open-label, randomized controlled trial (the OMAMA study).
    Kistemaker KRJ; de Graeff A; Crul M; de Klerk G; van de Ven PM; van der Meulen MP; van Zuylen L; Steegers MAH
    BMC Palliat Care; 2023 Mar; 22(1):22. PubMed ID: 36915062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Constipation in the United States: Results From a Population-Based Survey Assessing Healthcare Seeking and Use of Pharmacotherapy.
    Oh SJ; Fuller G; Patel D; Khalil C; Spalding W; Nag A; Spiegel BMR; Almario CV
    Am J Gastroenterol; 2020 Jun; 115(6):895-905. PubMed ID: 32324606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid-induced constipation, use of laxatives, and health-related quality of life.
    Christensen HN; Olsson U; From J; Breivik H
    Scand J Pain; 2016 Apr; 11():104-110. PubMed ID: 28850447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis.
    Kanbayashi Y; Shimizu M; Ishizuka Y; Sawa S; Yabe K; Uchida M
    PLoS One; 2022; 17(12):e0278823. PubMed ID: 36490241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Burden of Illness of Rome IV Irritable Bowel Syndrome in the United States: Results From a Nationwide Cross-Sectional Study.
    Almario CV; Sharabi E; Chey WD; Lauzon M; Higgins CS; Spiegel BMR
    Gastroenterology; 2023 Dec; 165(6):1475-1487. PubMed ID: 37595647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and Associated Costs of Constipation Relating to Exposure to Strong Opioids in England: An Observational Study.
    Morgan CL; Jenkins-Jones S; Knaggs R; Currie C; Conway P; Poole CD; Berni E
    Clin Ther; 2021 Jun; 43(6):968-989. PubMed ID: 33931241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When People with Opioid-Induced Constipation Speak: A Patient Survey.
    Epstein RS; Teagarden JR; Cimen A; Sostek M; Salimi T
    Adv Ther; 2017 Mar; 34(3):725-731. PubMed ID: 28181146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Lubiprostone, an Intestinal Secretagogue, on Electrolyte Homeostasis in Chronic Idiopathic and Opioid-induced Constipation.
    Rao SSC; Lichtlen P; Habibi S
    J Clin Gastroenterol; 2021 Jul; 55(6):512-519. PubMed ID: 32569031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid-Induced Constipation Among Patients with Chronic Noncancer Pain in the United States, Canada, Germany, and the United Kingdom: Laxative Use, Response, and Symptom Burden Over Time.
    Coyne KS; Margolis MK; Yeomans K; King FR; Chavoshi S; Payne KA; LoCasale RJ
    Pain Med; 2015 Aug; 16(8):1551-65. PubMed ID: 25802051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for opioid-induced constipation in cancer patients: a single-institution, retrospective analysis.
    Kanbayashi Y; Ishizuka Y; Shimizu M; Sawa S; Yabe K; Uchida M
    Support Care Cancer; 2022 Jul; 30(7):5831-5836. PubMed ID: 35355120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.